About Castle Creek Biosciences
Castle Creek Biosciences is a private company based in Exton, Pennsylvania. It has reported $839,779,367 raised in six offerings on Form D since October 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2025 | Feb 25, 2025 | $75,000,000fully sold | 30 | $2.5M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 19, 2022 | May 2, 2022 | $112,782,892fully sold | 54 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Jan 18, 2022 | Feb 3, 2022 | $11,850,000fully sold | 6 | $1.9M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 28, 2021 | Jul 9, 2021 | $25,000,000fully sold | 36 | $694K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 9, 2019 | Jan 21, 2020 | $54,602,249fully sold | 12 | $4.5M | EquityRule 506(b) | Form D ↗ |
| Oct 9, 2018 | Oct 24, 2018 | $560,544,226fully sold | 19 | $29.5M | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $839,779,367 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Castle Creek Biosciences's Form D filed Feb 25, 2025.
Earlier filings also listed W. Middlekauff (secretary, last listed May 2022), Mary Spellman (executive officer, last listed May 2022), Mark Graf (director, last listed May 2022), Babar Ghias (executive officer, last listed Feb 2022), Gregory Wujek (executive officer, last listed Jul 2021), Gregory MacMichael (executive officer, last listed Jul 2021), Timothy Cunniff (director, last listed Jan 2020) and Michael Derby (chief executive officer and director, last listed Oct 2018).